 BALTIMORE, July 06, 2022 GLOBE NEWSWIRE -- Graybug Vision, Inc. Nasdaq: GRAY, a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced a platform presentation at the upcoming Ophthalmology Innovation Source OIS Retina Innovation Summit, to be held in New York City on July 13, 2022. 